$5.64 Billion is the total value of HHLR ADVISORS, LTD.'s 70 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIDU | New | BAIDU INCspon adr rep a | $61,258,428 | – | 405,900 | +100.0% | 1.09% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $30,017,307 | – | 308,693 | +100.0% | 0.53% | – |
| LI | New | LI AUTO INCsponsored ads | $25,722,751 | – | 1,030,972 | +100.0% | 0.46% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $14,870,346 | – | 25,800 | +100.0% | 0.26% | – |
| ZTO | New | ZTO EXPRESS CAYMAN INCsponsored ads a | $12,338,130 | – | 430,500 | +100.0% | 0.22% | – |
| CTLT | New | CATALENT INC | $12,287,770 | – | 187,000 | +100.0% | 0.22% | – |
| EXAS | New | EXACT SCIENCES CORP | $11,534,074 | – | 170,094 | +100.0% | 0.20% | – |
| SNY | New | SANOFIsponsored adr | $11,194,194 | – | 205,700 | +100.0% | 0.20% | – |
| AMD | New | ADVANCED MICRO DEVICES INC | $11,084,931 | – | 113,100 | +100.0% | 0.20% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $10,270,875 | – | 12,500 | +100.0% | 0.18% | – |
| SGEN | New | SEAGEN INC | $7,764,725 | – | 38,350 | +100.0% | 0.14% | – |
| New | WOLFSPEED INC | $4,546,500 | – | 70,000 | +100.0% | 0.08% | – | |
| SRPT | New | SAREPTA THERAPEUTICS INC | $1,433,983 | – | 10,404 | +100.0% | 0.02% | – |
| New | YS BIOPHARMA CO LTDordinary shares | $1,202,864 | – | 751,790 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.